Cutaneous manifestations of category A bioweapons - 12/11/11
Reprint requests: Jashin J. Wu, MD, Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, 1515 N Vermont Ave, 5th Floor, Los Angeles, CA 90027.Abstract |
The 2001 anthrax attacks on the United States brought bioterrorism to the forefront of the medical community. Because many bioterrorist agents produce cutaneous disease, dermatologists will likely be first responders during a future attack. Despite this, many dermatologists are not adequately prepared to deal with a bioterrorism attack. It is critical that all first responders be able to recognize symptoms of bioterrorism-related disease and prepared to respond to a bioterrorist attack to minimize threats to public health. This article reviews the diagnosis and treatment of diseases caused by potential biowarfare agents that produce cutaneous manifestations, and also provides information regarding reporting and containment of possible bioterrorism-related diseases.
Le texte complet de cet article est disponible en PDF.Key words : anthrax, bioterrorism, fever, plague, public health, smallpox, tularemia, viral hemorrhagic
Abbreviations used : CDC, PCR, WHO
Plan
| Funding sources: None. |
|
| Conflicts of interest: None declared. |
Vol 65 - N° 6
P. 1213.e1-1213.e15 - décembre 2011 Retour au numéro
Article précédent
- Ocular psoriasis
- Balvinder Rehal, Bobeck S. Modjtahedi, Lawrence S. Morse, Ivan R. Schwab, Howard I. Maibach
- Onychomycosis: A proposed revision of the clinical classification
- Roderick J. Hay, Robert Baran
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?